Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.63 USD | +6.28% | +4.35% | +8.42% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 976M |
---|---|---|---|---|---|
Net income 2024 * | -182M | Net income 2025 * | -206M | EV / Sales 2024 * | - |
Net cash position 2024 * | 207M | Net cash position 2025 * | 168M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.57
x | P/E ratio 2025 * |
-5.28
x | Employees | 77 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.4% |
Latest transcript on Centessa Pharmaceuticals plc
1 day | +6.28% | ||
1 week | +4.35% | ||
1 month | -5.79% | ||
3 months | -17.89% | ||
6 months | +43.83% | ||
Current year | +8.42% |
Managers | Title | Age | Since |
---|---|---|---|
Saurabh Saha
CEO | Chief Executive Officer | 47 | 20-12-31 |
Director of Finance/CFO | 53 | 21-02-28 | |
Ellie Im
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 61 | 21-02-22 | |
Chairman | 54 | 20-10-31 | |
Brett Zbar
BRD | Director/Board Member | 51 | 20-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 8.63 | +6.28% | 165,406 |
24-05-30 | 8.12 | +1.00% | 62,414 |
24-05-29 | 8.04 | -0.74% | 124,098 |
24-05-28 | 8.1 | -2.06% | 124,654 |
24-05-24 | 8.27 | -0.96% | 108,684 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.42% | 976M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- CNTA Stock